World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
40843
World Ranking
12014
National Ranking
6159

Overview

Bonnie W. Ramsey is affiliated with the University of Washington in the United States. Their research primarily focuses on medicine, with a strong emphasis on pulmonary and respiratory medicine. Additional subfields of study include epidemiology, plant science, emergency medical services, and molecular biology.

The scientist's main topics of work cover a variety of areas related to respiratory health and disease, specifically:

  • Cystic Fibrosis Research Advances
  • Neonatal Respiratory Health Research
  • Tracheal and Airway Disorders
  • Respiratory Viral Infections Research
  • Pediatric Health and Respiratory Diseases
  • Nematode Management and Characterization Studies
  • Bacterial Biofilms and Quorum Sensing

Bonnie W. Ramsey has contributed extensively to research on cystic fibrosis and related respiratory conditions. Their recent notable publications include:

  • A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele (2021) published in American Journal of Respiratory and Critical Care Medicine
  • Triple Therapy for Cystic Fibrosis Phe508del -Gating and -Residual Function Genotypes (2021) published in New England Journal of Medicine
  • Cystic Fibrosis (2023) published in JAMA
  • Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis and at Least One F508del Allele: 144-Week Interim Results from a 192-Week Open-Label Extension Study (2023) published in European Respiratory Journal
  • Safety and Efficacy of Vanzacaftor-Tezacaftor-Deutivacaftor in Adults with Cystic Fibrosis: Randomised, Double-blind, Controlled, Phase 2 Trials (2023) published in The Lancet Respiratory Medicine

Their frequent coauthors include:

  • Jennifer L. Taylor-Cousar
  • Marcus Mall
  • Edward F. McKone
  • Elizabeth Tullis
  • George Retsch-Bogart

They have published extensively in several venues, with notable numbers of publications in:

  • Journal of Cystic Fibrosis
  • UNC Libraries
  • American Journal of Respiratory and Critical Care Medicine
  • The Lancet Respiratory Medicine
  • JAMA

Best Publications

  • A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

    Bonnie W. Ramsey;Jane Davies;N. Gerard McElvaney;Elizabeth Tullis

  • Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis

    Henry J. Fuchs;Drucy S. Borowitz;David H. Christiansen;Edward M. Morris

  • Pathophysiology and management of pulmonary infections in cystic fibrosis.

    Ronald L. Gibson;Jane L. Burns;Bonnie W. Ramsey

  • Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis

    B W Ramsey;M S Pepe;J M Quan;K L Otto

  • Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

    Jennifer L Taylor-Cousar;Anne Munck;Edward F McKone;Cornelis K van der Ent

  • Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

    Peter G. Middleton;Marcus A. Mall;Pavel Dřevínek;Larry C. Lands

  • Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

    Eric E. Smith;Danielle G. Buckley;Zaining Wu;Channakhone Saenphimmachak

  • Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

    Julia Emerson;Julia Emerson;Margaret Rosenfeld;Margaret Rosenfeld;Sharon McNamara;Bonnie Ramsey;Bonnie Ramsey

  • Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation : a double-blind, randomised, phase 3 trial

    Harry G M Heijerman;Edward F McKone;Damian G Downey;Eva Van Braeckel

  • Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

    Frank J. Accurso;Steven M. Rowe;J. P. Clancy;Michael P. Boyle

  • Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.

    Jane L. Burns;Ronald L. Gibson;Sharon McNamara;Darlene Yim

  • Management of Pulmonary Disease in Patients with Cystic Fibrosis

    Bonnie W. Ramsey

  • Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

    B W Ramsey;H L Dorkin;J D Eisenberg;R L Gibson

  • VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

    Dominic Keating;Gautham Marigowda;Lucy Burr;Cori Daines

  • Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States

    Jane L. Burns;Julia Emerson;Jenny R. Stapp;Darlene L. Yim

  • Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa

    Lucas R. Hoffman;Éric Déziel;David A D'Argenio;François Lépine

  • Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis.

    Margaret Rosenfeld;Ronald L. Gibson;Sharon McNamara;Julia Emerson

  • Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis

    Steven M. Rowe;Sonya L. Heltshe;Sonya L. Heltshe;Tanja Gonska;Scott H. Donaldson

  • Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.

    David E. Geller;William H. Pitlick;Pasqua A. Nardella;William G. Tracewell

  • Gender Gap in Cystic Fibrosis Mortality

    Margaret Rosenfeld;Robert Davis;Stacey FitzSimmons;Margaret Pepe

Frequent Co-Authors

Arnold L. Smith
Arnold L. Smith Center for Infectious Disease Research
Margaret Rosenfeld
Margaret Rosenfeld University of Washington
Jane L. Burns
Jane L. Burns University of Washington
Michael W. Konstan
Michael W. Konstan Case Western Reserve University
Richard B. Moss
Richard B. Moss Stanford University
Richard A. Kronmal
Richard A. Kronmal University of Washington
John P. Clancy
John P. Clancy Cystic Fibrosis Foundation
Steven M. Rowe
Steven M. Rowe University of Alabama at Birmingham
Lucas R. Hoffman
Lucas R. Hoffman University of Washington
Pamela L. Zeitlin
Pamela L. Zeitlin National Jewish Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, there are many online degree options and career pathways worth considering. For those who want to advance quickly into nursing, online direct entry msn programs are an efficient route—ideal for non-nurses aiming to earn a master’s degree and enter the field at an advanced level.

Not all programs require top grades or competitive test scores. Some easy nursing schools to get into offer more accessible admission criteria, helping students begin their healthcare journey without unnecessary hurdles. Additionally, if standardized tests are a concern, you may be glad to know that not do all nursing schools require the teas or HESI exams, which can open up more accessible opportunities.

For those interested in healthcare careers that don’t require direct patient care, accredited medical billing and coding schools online with financial aid are available. These programs can be completed remotely and often offer flexible schedules, making them a great option for working adults and career changers. Each pathway offers its own advantages—helping you find the right fit in the dynamic world of medicine and healthcare.

Best Scientists Citing Bonnie W. Ramsey

Trending Scientists

Recently Published Articles